Literature DB >> 28796444

The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis.

V Chopra1,2,3, S Kaatz4, A Conlon1,2, D Paje1,2, P J Grant1,3, M A M Rogers1,3, S J Bernstein1,2,3, S Saint1,2, S A Flanders1,3.   

Abstract

Essentials How best to quantify thrombosis risk with peripherally inserted central catheters (PICC) is unknown. Data from a registry were used to develop the Michigan Risk Score (MRS) for PICC thrombosis. Five risk factors were associated with PICC thrombosis and used to develop a risk score. MRS was predictive of the risk of PICC thrombosis and can be useful in clinical practice.
SUMMARY: Background Peripherally inserted central catheters (PICCs) are associated with upper extremity deep vein thrombosis (DVT). We developed a score to predict risk of PICC-related thrombosis. Methods Using data from the Michigan Hospital Medicine Safety Consortium, image-confirmed upper-extremity DVT cases were identified. A logistic, mixed-effects model with hospital-specific random intercepts was used to identify factors associated with PICC-DVT. Points were assigned to each predictor, stratifying patients into four classes of risk. Internal validation was performed by bootstrapping with assessment of calibration and discrimination of the model. Results Of 23 010 patients who received PICCs, 475 (2.1%) developed symptomatic PICC-DVT. Risk factors associated with PICC-DVT included: history of DVT; multi-lumen PICC; active cancer; presence of another CVC when the PICC was placed; and white blood cell count greater than 12 000. Four risk classes were created based on thrombosis risk. Thrombosis rates were 0.9% for class I, 1.6% for class II, 2.7% for class III and 4.7% for class IV, with marginal predicted probabilities of 0.9% (0.7, 1.2), 1.5% (1.2, 1.9), 2.6% (2.2, 3.0) and 4.5% (3.7, 5.4) for classes I, II, III, and IV, respectively. The risk classification rule was strongly associated with PICC-DVT, with odds ratios of 1.68 (95% CI, 1.19, 2.37), 2.90 (95% CI, 2.09, 4.01) and 5.20 (95% CI, 3.65, 7.42) for risk classes II, III and IV vs. risk class I, respectively. Conclusion The Michigan PICC-DVT Risk Score offers a novel way to estimate risk of DVT associated with PICCs and can help inform appropriateness of PICC insertion.
© 2017 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  deep vein thrombosis; peripherally inserted central catheter; thrombosis; upper extremity; venous thromboembolism

Mesh:

Year:  2017        PMID: 28796444     DOI: 10.1111/jth.13794

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  21 in total

1.  Persistent Barriers to Timely Catheter Removal Identified from Clinical Observations and Interviews.

Authors:  Martha Quinn; Jessica M Ameling; Jane Forman; Sarah L Krein; Milisa Manojlovich; Karen E Fowler; Elizabeth A King; Jennifer Meddings
Journal:  Jt Comm J Qual Patient Saf       Date:  2019-12-23

2.  A model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer: a retrospective cohort study.

Authors:  Si-Yi Peng; Tao Wei; Xu-Ying Li; Zhong Yuan; Qin Lin
Journal:  Support Care Cancer       Date:  2021-08-25       Impact factor: 3.603

3.  Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care.

Authors:  Juan Carlos Laguna; Tim Cooksley; Shin Ahn; Nikolaos Tsoukalas; Thein Hlaing Oo; Norman Brito-Dellan; Francis Esposito; Carmen Escalante; Carme Font
Journal:  Support Care Cancer       Date:  2022-08-06       Impact factor: 3.359

4.  A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies.

Authors:  Jing Yue; Ya Zhang; Fang Xu; Ai Mi; Qiaolin Zhou; Bin Chen; Lin Shi
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

5.  Conditional catheter-related thrombosis free probability and risk-adapted choices of catheter for lung cancer.

Authors:  Yanfeng Wang; Chanjuan Cui; Xin Liu; Lei Deng; Ke Yang; Bin Li; Jie Xue; Junying Xie; Wei Cui
Journal:  Thorac Cancer       Date:  2022-05-13       Impact factor: 3.223

Review 6.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

7.  Peripherally Inserted Central Catheters in the ICU: A Retrospective Study of Adult Medical Patients in 52 Hospitals.

Authors:  Sushant Govindan; Ashley Snyder; Scott A Flanders; Vineet Chopra
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

8.  Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study.

Authors:  Yan Fu; Qiufen Xiang; Lingling Xie; Yue Feng; Chunhua Yu; Junying Li
Journal:  Support Care Cancer       Date:  2021-04-24       Impact factor: 3.603

9.  A Practical Guide for Building Collaborations Between Clinical Researchers and Engineers: Lessons Learned From a Multidisciplinary Patient Safety Project.

Authors:  Roshun R Sankaran; Jessica M Ameling; Amy E M Cohn; Cyril M Grum; Jennifer Meddings
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.243

10.  Peripherally inserted central venous catheter (PICC) in outpatient and inpatient oncological treatment.

Authors:  Dorothea Mielke; Andrea Wittig; Ulf Teichgräber
Journal:  Support Care Cancer       Date:  2020-01-22       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.